Related Experiment Video
Updated: Jun 21, 2025
07:40
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
4.8K
microRNA 146a ameliorates retinal damage in experimental autoimmune uveitis.
Sindhu Saraswathy1, Narsing A Rao2
1Department of Ophthalmology, Doheny Eye Institute, Los Angeles, CA, United States.
Frontiers in Ophthalmology
|July 10, 2024
Summary
MicroRNA 146a, upregulated during experimental autoimmune uveitis (EAU) treatment, protected photoreceptor cells. This microRNA shows potential as a novel therapeutic agent for preventing vision loss in uveitis patients.
Area of Science:
- Ophthalmology
- Immunology
- Molecular Biology
Background:
- Uveitis causes blindness through photoreceptor cell damage.
- Mitochondrial oxidative stress and alphaA crystallin upregulation occur in experimental autoimmune uveitis (EAU).
- AlphaA crystallin treatment in EAU reduced oxidative stress by suppressing immune responses.
Purpose of the Study:
- Investigate microRNA modulation during EAU development with alphaA crystallin administration.
- Explore microRNA therapeutic intervention for EAU.
Main Methods:
- Studied microRNA changes in EAU mice treated with alphaA crystallin.
- Utilized computational bioinformatics to identify microRNA targets.
- Administered microRNA 146a intravenously and intravitreally in EAU models.
Main Results:
- AlphaA crystallin administration upregulated specific microRNAs in EAU mice.
- MicroRNA 146a was identified to target innate and adaptive immune responses.
- MicroRNA 146a administration prevented inflammatory cell infiltration and preserved photoreceptor cells in EAU.
Conclusions:
- MicroRNA 146a plays a role in modulating immune responses in EAU.
- MicroRNA 146a demonstrates protective effects on retinal and photoreceptor cells.
- MicroRNA 146a is a potential novel therapeutic agent for uveitis.
